Kraig Biocraft Laboratories Launches Commercial Production of Monster Silk(TM)
October 07 2013 - 6:05AM
Kraig Biocraft Laboratories, Inc. (OTCQB:KBLB) ("Company"), the
leading developer of advanced spider silk based fibers, today
announced the launching of the Company's commercial production
program with the recent hatching of its first batch of Monster
Silk™ silkworms for commercial production.
Furthermore, the Company is currently expending resources to
augment the scale of its Monster Silkworm™ production over the next
30 to 90 days. This move coincides with the Company's planned
strategy to rapidly increase its production capacity. The
Company's strategy is to commit the vast majority of its initial
production capacity to a propagation program designed to increase
its production population. A smaller portion of the first
commercial production generation should also yield fibers which can
be dedicated to the production of woven textile samples.
"Our launch of our commercial scale production of Monster Silk™
is a long awaited major milestone for Kraig, as we demonstrate our
ability to convert recombinant spider silk, and Monster Silk™ most
specifically, from an exciting laboratory technology to a
marketable product," said, CEO and founder, Kim K.
Thompson. "We believe that rolling out the world's first
recombinant spider silk commercial production project will only
expand our global development prospects, for Monster Silk™ and
other high technology fibers."
"It has taken many years to go from my initial concept of
recombinant spider silk to the laboratory production of Monster
Silk™ and now the actual launch and scaling up of the commercial
scale production. I want to thank our investors and, most
particularly, the research scientists, whose work and dedication
has made this long anticipated day possible."
"Given the current planned production schedule, we could
theoretically be producing Monster Silk™ in metric ton quantities
by early January. A more conservative estimate, given the
realities of launching such a ground breaking and commercially
unique project, would be to reach that major milestone in mid
2014. This move reaffirms our view that Kraig is the world's
leading developer of recombinant spider silk technologies,"
concluded Thompson.
About Kraig Biocraft Laboratories, Inc.
Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com), a fully
reporting biotechnology company is the leading developer of
genetically engineered spider silk based fiber technologies. The
Company has achieved a series of scientific breakthroughs in the
area of spider silk technology with implications for the global
textile industry.
Cautionary Statement Regarding Forward Looking Information
Statements in this press release about the Company's future and
expectations other than historical facts are "forward-looking
statements." These statements are made on the basis of management's
current views and assumptions. As a result, there can be no
assurance that management's expectations will necessarily come to
pass. These forward-looking statements generally can be identified
by phrases such as "believes," "plans," "expects," "anticipates,"
"foresees," "estimated," "hopes," "if," "develops," "researching,"
"research," "pilot," "potential," "could" or other words or phrases
of similar import. Forward looking statements include descriptions
of the Company's business strategy, outlook, objectives, plans,
intentions and goals. All such forward-looking statements are
subject to certain risks and uncertainties that could cause actual
results to differ materially from those in forward-looking
statements.
This press release does not constitute an offer to sell or the
solicitation of an offer to buy any security.
CONTACT: Ben Hansel, Hansel Capital, LLC.
(720) 288-8495
ir@KraigLabs.com
Kraig Biocraft Laborator... (QB) (USOTC:KBLB)
Historical Stock Chart
From May 2024 to Jun 2024
Kraig Biocraft Laborator... (QB) (USOTC:KBLB)
Historical Stock Chart
From Jun 2023 to Jun 2024